This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Fifteen deals receive unconditional antitrust clearance in China Nov. 25-Dec. 1

( December 3, 2019, 09:31 GMT | Official Statement) -- MLex Summary: US biopharmaceutical company AbbVie’s acquisition of rival Allergan; a joint venture between North Huajin Chemical Industries Group and petroleum and natural-gas company Saudi Aramco Asia; and poultry-processing company Wens Foodstuff Group’s purchase of an 80 percent stake in Jiangsu Jinghai Poultry Industry Group are among 15 deals that received unconditional approval from the Antimonopoly Bureau of China’s State Administration for Market Regulation between Nov. 25 and Dec. 1, according to a list of deals published today by the regulator.The list of deals is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections